EGFR and neoplasm: Herein, we developed an epidermal growth factor receptor (EGFR) targeted ultra‐pH‐sensitive nanophotosensitizer, and systemically investigated its active targeting ability and therapeutic efficacy after the regulation of tumor vasculature and stromal barriers.